The global angiography catheters market is set to grow steadily at a CAGR of above 4 percent by 2021. One of the primary drivers for this market is the rise in incidences of cardiac diseases and insurance providers. High blood pressure is one of the highest risk factors for coronary artery disease (CAD). It is caused due to atherosclerosis (formation of plaque in the blood vessels), which can interrupt the blood circulation and lead to a heart attack or stroke. This has compelled several governments to initiate cardiac care programs for the population. It has also been estimated that the coronary heart disease was the most common cardiac disease found among the population. To treat these diseases, physicians diagnose and may recommend surgeries based on the stage of the disease. Consequently, to provide better treatment, governments offer reimbursement plan, which can cover the treatment cost. This will lead most of the people to opt for early treatment plan such as angiography. This, in turn, will drive the global angiography catheters market over the next 5 years.
The global angiography catheters market is growing steadily and is likely to grow at a significant pace over the next 5 years, according to a report by Technavio. This is due to the presence of many global and regional vendors that offer a wide range of angiography catheters. Also, it has been noted that the Tier-I and Tier-II companies dominate the market. In an attempt to gain a competitive advantage, vendors are increasingly focused on advanced technologies to develop new products.
Leading vendors in the market are Boston Scientific, C. R. Bard, and Medtronic. Other prominent vendors in the angiography catheters market include Aachen Resonance, Abbott Laboratories, Abiomed, Acrostak, AdvanSource Biomaterials, AGA Medical, Allium Medical, Alvimedica, AMG International, AngioDynamics, Angioslide, Arstasis, Arthesys, Asahi Intecc, Atrium Medical, AV Medical, B. Braun Melsungen, Beijing Puyishengji Medical Technology, Biophan Technologies, Biosense Webster, Biotronik, BrosMed, Cardiac Science, CardiacAssist, Dextera Surgical, Cardio-Flow, Cardionovum, Claret Medical, Contego Medical, Cook Group, Cryolife, Edward Lifesciences, Endocor, Essential Medical, GaltNeedleTech, Innovative Cardiovascular Solutions, InSeal Medical, JOTEC, Kaneka Medix, Keystone Heart, Lepu Medical, Medeon Biodesign, Medinol, Meril Life Sciences, Merit Medical Systems, MicroPort Scientific, Morris Innovative, Natec Medical, OptiMed, QT Vascular, Shockwave Medical, Smiths Medical, Spectranetics, Stentys, Svelte medical, Teleflex, Tokai Medical, Transluminal Technologies, Transverse Medical, US Endovascular, Vascular Closure Systems, Vasorum, Vivasure Medical, and Volcano.
In terms of geography, the Americas accounted for the maximum market share during 2016 and will continue to dominate the market for the next few years. The US is the leading contributor to the market in the region. Cardiovascular diseases (CVDs) (heart valve problems, arrhythmia, heart attack, and stroke) are the leading causes of deaths in the Americas. Also, it is expected that the incidence of CVDs will rise in the coming years. Further, CAD causes blockage in the artery characterized by the deposition of fatty substances that leads to the narrowing of blood vessels and interrupting the supply of blood to the heart. To assess the complexities of such diseases, physicians perform angiography by using angiography catheters and imaging devices such as PET angiography, coronary CT angiography, and X-ray scan (non-invasive methods). This will augment growth in the global angiography catheters market in the coming years.